Advertisement

Topics

Bacchus Vascular, Inc. Company Profile

18:39 EDT 22nd September 2017 | BioPortfolio

Bacchus Vascular, Inc. is a privately held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. Thousands of patients suffering from DVT and other occlusive vascular diseases have been treated worldwide to date using the company's Trellis(R) Peripheral Infusion System and other products.


News Articles [354 Associated News Articles listed on BioPortfolio]

Velano Vascular and Partners to Address Medical Device Innovation and Vascular Access Advances ...

SAN FRANCISCO, CA--(Marketwired - Sep 14, 2017) - Vascular access technology innovator Velano Vasculartoday announced that company leadership and several partners will present at Read more...

Vascular disease: Benefits of population screening for vascular risk

A French Biotech Planning to Take Vascular Medical Devices to the Next Level

This week we are just outside Paris visiting Sensome, a biotech developing exciting technology to turn vascular medical devices into connected healthcare devices. Mission: Sensome’s big aim is t...

Abbott pulls troubled Absorb stents from worldwide market

In an 82-word statement posted Friday, Sept. 8,

QT Vascular negotiating deals for coronary assets

Singapore-based QT Vascular has announced that it is in talks with interested third parties to seek out potential deals for i -More- 

Vascular Surgery Complications Increased by Hyperglycemia

Hyperglycemia can increase complications and mortality in patients undergoing vascular procedures, including those who are not diabetic, according to a...

New York City Vascular Surgeon Dr. Alan Benvenisty Named “Top Doctor” by Castle Connolly

New York, New York (PRWEB) May 24, 2017 Dr. Alan I. Benvenisty, MD is dual board certified in general surgery and general vascular ...

Intact Vascular secures FDA approval to modify balloon angioplasty trial

The FDA has given Intact Vascular a supplemental investigational device exemption to change the 12-month primary endpoint in  -More- 

PubMed Articles [1417 Associated PubMed Articles listed on BioPortfolio]

Outcomes for cervicomediastinal vascular trauma managed by a vascular subspecialistled vascular trauma service.

The management of cervicomediastinal vascular trauma is challenging. We report on our experience with the condition in a newly established vascular trauma service unit, and compare the outcomes to tho...

Variability in 2-year training programs in vascular surgery based on results of an Association of Program Directors in Vascular Surgery survey.

Although a great deal of attention has recently focused on 5-year integrated (0+5) training programs in vascular surgery, a paucity of data exists concerning variability of daily assignments in 2-year...

Quality and Safety in Health Care, Part XXIV: More on Vascular Surgery.

The use of registries such as the Vascular Quality Initiative and its regional groups, such as the Vascular Study Group of New England, have been very helpful in investigating problems related to qual...

Protective Function of Ahnak1 in Vascular Healing after Wire Injury.

Vascular remodeling following injury substantially accounts for restenosis and adverse clinical outcomes. In this study, we investigated the role of the giant scaffold protein Ahnak1 in vascular heali...

Efficacy of statin on vascular access patency in diabetic hemodialysis patients.

An effective approach to prevent hemodialysis vascular access dysfunction is still unclear despite previous studies, which have shown conflicting results of several drugs on vascular access outcomes. ...

Clinical Trials [1530 Associated Clinical Trials listed on BioPortfolio]

Patient Comfort With Vascular Closure

The purpose of this research study is to collect information on the amount of discomfort patients experience with one of two different vascular blood vessel closure devices, the MynxM5 Vas...

Clinical Study of POSS-PCU Vascular Grafts for Vascular Access

This study evaluates the safety and performance of a new vascular graft made of POSS-PCU as a vascular access conduit for haemodialysis. 30 patients requiring access for dialysis will be e...

Study to Evaluate Safety & Effectiveness of Vascular Sealant System

To evaluate a new vascular sealant compared to control for the control of suture line bleeding after vascular reconstructive surgery.

Correlation Between Circulating Resistin and Vascular Inflammation Measured by 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) (18FDG-PET)

Vascular inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis.Resistin was shown to induce vascular endothelial dysfunction and vascular smooth muscle cell ...

A Study to Evaluate the Safety and Performance of ArterX™ Vascular Sealant in Sealing Synthetic Arterial Grafts

A prospective, multi-center study to evaluate the safety and performance outcomes of the ArterX Vascular Sealant when used for prophylactic sealing of suture lines at the anastomosis betwe...

Companies [306 Associated Companies listed on BioPortfolio]

Bacchus Vascular, Inc.

Bacchus Vascular, Inc. is a privately held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founde...

Atherton Venture Partners, LLC

Bacchus Vascular, Inc. is developing a safe, potentially less invasive, and more effective procedure to percutaneously remove blood clots from dialysis and peripheral grafts as well as native arteries...

LeMaitre Vascular

LeMaitre Vascular is a leading global provider of innovative devices for the treatment of peripheral vascular disease. We develop, manufacture, and market disposable and implantable vascular devices t...

The Foundation for Accelerated Vascular Research

The Foundation for Accelerated Vascular Research is a non-profit medical organization dedicated to accelerating research into the cause, prevention and treatment of vascular disease. Founded in 19...

Society for Vascular Surgery

The Society for Vascular Surgery (SVS) is a not-for-profit professional medical society, composed primarily of vascular surgeons, that seeks to advance excellence and innovation in vascular health thr...

More Information about "Bacchus Vascular, Inc." on BioPortfolio

We have published hundreds of Bacchus Vascular, Inc. news stories on BioPortfolio along with dozens of Bacchus Vascular, Inc. Clinical Trials and PubMed Articles about Bacchus Vascular, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bacchus Vascular, Inc. Companies in our database. You can also find out about relevant Bacchus Vascular, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record